For investors only
All about the drug candidate arfolitixorin
and related information
ESMO-GI 2024, poster
Attikon University Hospital in Athen, Greece has got an abstract accepted to present at ESMO-GI 2024 between June 26-29 in Munich, Germany.
Information about the poster
Title: Final Analysis of the Greek cohort of the AGENT Phase III study Arfolitixorin in Metastatic Colorectal Cancer
Authors: Anna Koumarianou, Evangelos Bournakis, Athanasios Kotsakis, Anastasios Ntavatzikos, Katerina Kampoli, Nikolaos Kentepozidis, Lisa Skintemo, Roger Tell, Christos Papadimitriou.
Abstract Number: #786
Isofol will be present at ESMO-GI 2024 between June 26-29. Please contact Lisa Skintemo if you want to get in touch with us during these days.
The abstract was published online on ESMO’s website on 20 June and is also be available below:
The poster will be published after the congress and will also be available below:
Last updated 07-08-2024
